$AGX

Baugher Joshua Scott sold $557K of AGX

Baugher Joshua Scott (Chief Financial Officer) sold 760 shares of ARGAN INC (AGX) at an average of $733.30 ($732.83–$734.00, $0.56M total) across 2 trades on 2026-06-17.

Original reporting
SEC EDGAR · Baugher Joshua Scott
Published Jun 18, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AGX
Neutral
medium confidence
Mentioned
$AGX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AGXNeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (date, shares, price range, and post-transaction holdings). This can marginally influence sentiment but does not change the company’s disclosed fundamentals.

02

Market read

Use as a minor sentiment/positioning input; it is not a standalone fundamental catalyst.

03

What to watch

No 10b5-1 plan is stated, but the article provides only one sale event; traders should check for prior/ongoing insider patterns and whether other executives also sold around the same time.

Relevance 5/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-18 after-hours; reflects 2026-06-17 sale.

Background

The article is an SEC Form 4 insider transaction disclosure for ARGAN Inc (AGX).

Company-level read

Ticker impact

$AGXNeutralMedium confidence
Context

AGX CFO Baugher Joshua Scott filed an open-market sale of 760 shares at ~$733 on 2026-06-17, per SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any impact would be short-lived unless followed by additional insider selling or new company-specific catalysts.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a moderate dollar value, but it does not disclose new operating/regulatory/financial information.

Market effects

Minimal; this is company-specific insider activity with no sector-wide regulatory or earnings signal.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification/tax needs rather than bearish views, especially when not tied to a new negative event.

Key entities

  • ARGAN INC

    US-listed company whose CFO filed the insider sale (AGX).

  • Baugher Joshua Scott

    Chief Financial Officer reporting an open-market sale of 760 shares.

Related articles

$AGXMedAI 8/10

Why is Argan stock surging today? By Investing.com

Argan shares rose about 15.8% to around €75.70, a new 52-week high, after French logistics REIT Argan announced an all-share merger with Belgian counterpart WDP. Argan shareholders would receive 3 WDP shares plus €11 cash per share, implying ~€79.22 value and ~21% premium, with boards and major shareholders backing.

$LULUHighAI 9/10

Stocks making the biggest moves after hours: Lululemon Athletica, ServiceTitan, Argan and more

After-hours movers: Lululemon shares fell 10% after it cut full-year earnings and revenue guidance and its current-quarter outlook missed analyst expectations, per LSEG. Docusign slipped 4% as its Q2 revenue outlook ($865M–$869M) met but didn’t beat estimates. Guidewire dropped 16% on weaker adjusted gross margin. ServiceTitan rose 12% after raising full-year guidance.